ConductScience.org, home
A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D
API referenceFor AI assistants

Trial · NCT03546621

Results by group132

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 132

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
HDV RNA Response at Week 24Arm AResponder15Participants
HDV RNA Response at Week 24Arm BResponder16Participants
HDV RNA Response at Week 24Arm CResponder23Participants
HDV RNA Response at Week 24Arm DResponder1Participants
HDV RNA Response at Week 24Arm ANon-Responder13Participants
HDV RNA Response at Week 24Arm BNon-Responder16Participants
HDV RNA Response at Week 24Arm CNon-Responder7Participants
HDV RNA Response at Week 24Arm DNon-Responder27Participants
Durability of HDV RNA ResponseArm AResponse at Week 24 only15Participants
Durability of HDV RNA ResponseArm BResponse at Week 24 only16Participants
Durability of HDV RNA ResponseArm CResponse at Week 24 only23Participants
Durability of HDV RNA ResponseArm DResponse at Week 24 only1Participants
Durability of HDV RNA ResponseArm AResponse at Week 24 and 482Participants
Durability of HDV RNA ResponseArm BResponse at Week 24 and 481Participants
Durability of HDV RNA ResponseArm CResponse at Week 24 and 483Participants
Durability of HDV RNA ResponseArm DResponse at Week 24 and 480Participants
Combined Response: HDV RNA Response and Normal ALT at Treatment Week 24Arm AWeek 24 / Responder6Participants
Combined Response: HDV RNA Response and Normal ALT at Treatment Week 24Arm BWeek 24 / Responder9Participants
Combined Response: HDV RNA Response and Normal ALT at Treatment Week 24Arm CWeek 24 / Responder11Participants
Combined Response: HDV RNA Response and Normal ALT at Treatment Week 24Arm DWeek 24 / Responder0Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03546621/results

API referenceFor AI assistants